Merck-Sponsored Report Finds Managers Didn't Conceal Vioxx Concerns



DOCUMENTS
  • Bowen Letter


WHITEHOUSE STATION, N.J. - A report commissioned by Merck & Co. Inc. and based on a 20-month internal investigation found that the drug manufacturer's senior executives did not knowingly put patients at risk or hide safety information in developing and marketing Vioxx.

The Sept. 6 report, on which Merck spent approximately $21 million, criticized certain Merck promotional activity but generally absolved the company's top management.

A Special Committee of the Merck Board of Directors in December 2004 retained former U.S. District Court Judge John S. Martin Jr. of the law firm Debevoise & Plimpton in New York to conduct the …






UPCOMING CONFERENCES




HarrisMartin's Data Breach Litigation Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS